Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.460
-0.110 (-2.41%)
At close: Jul 13, 2026, 4:00 PM EDT
4.410
-0.050 (-1.12%)
After-hours: Jul 13, 2026, 4:10 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $14.31 million as of July 13, 2026. Its market cap has decreased by -30.24% in one year.
Market Cap
14.31M
Enterprise Value
-13.43M
1-Year Change
-30.24%
Ranking
Category
Stock Price
$4.46
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $14.31M, a decrease of -98.50%. That is a compound annual growth rate of -48.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 14.31M | -61.86% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 16.27M |
| Jasper Therapeutics | 16.22M |
| Lexaria Bioscience | 16.03M |
| Citius Pharmaceuticals | 16.00M |
| Vyome Holdings | 15.79M |
| GT Biopharma | 15.33M |
| Moolec Science | 15.25M |
| CalciMedica | 14.69M |